Updates are available Correction dated 2022-09-20
Click to view Correction: https://doi.org/10.1186/s13059-022-02773-0
-
Authors
Liu, Zhichao
Roberts, Ruth
Mercer, Timothy R.
Xu, Joshua
Sedlazeck, Fritz J.
Tong, Weida http://orcid.org/0000-0003-3488-6148
-
Funding
Funding for this research was provided by:
UM1 (HG008898)
National Institutes of Health (1U01HG011758-01)
- License Information
-
More Information
Article History
Received: 27 August 2021
Accepted: 15 February 2022
First Online: 3 March 2022
Change Date: 20 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13059-022-02773-0
Declarations
:
: Not applicable.
: RR is co-founder and co-director of ApconiX, an integrated toxicology and ion channel company that provides expert advice on non-clinical aspects of drug discovery and drug development to academia, industry, and not-for-profit organizations. FJS received travel reimbursements from Pacbio and Oxford Nanopore.
